300119SZSE
🚨 Material Event

Announcement on Obtaining New Veterinary Drug Registration Certificates

✨ AI Summary

The company, Ruipu Biological, and its subsidiaries have received new veterinary drug registration certificates from the Ministry of Agriculture and Rural Affairs. The approved drugs, Grapiprant and Grapiprant Tablets, represent significant innovations in pet orthopedic anti-inflammatory treatments. This approval enhances the company's competitive edge in the high-end veterinary drug market and provides safer, more effective treatment options for veterinarians and pet owners.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Ruipu Biological Co., Ltd. and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.

According to the "Veterinary Drug Management Regulations" and "Veterinary Drug Registration Measures," Ruipu Biological Co., Ltd. (hereinafter referred to as "the Company" or "Ruipu Biological"), its wholly-owned subsidiary Ruipu (Tianjin) Biological Pharmaceutical Co., Ltd., and its holding subsidiary Hubei Longxiang Pharmaceutical Technology Co., Ltd. have recently obtained new veterinary drug registration certificates issued by the Ministry of Agriculture and Rural Affairs. The details are as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.